Skip to main content

and
Your search also matched 2 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Clinical value of molecular subty** multiple myeloma using gene expression profiling

Include preview-only content
  1. Article

    Open Access

    Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control

    Myeloma is heterogeneous at the molecular level with subgroups of patients characterised by features of epigenetic dysregulation. Outcomes for myeloma patients have improved over the past few decades except fo...

    C Pawlyn, M D Bright, A F Buros, C K Stein, Z Walters, L I Aronson in Blood Cancer Journal (2017)

  2. Article

    Open Access

    Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

    The purpose of this study is to identify prognostic markers and treatment targets using a clinically certified sequencing panel in multiple myeloma. We performed targeted sequencing of 578 individuals with pla...

    S S Chavan, J He, R Tytarenko, S Deshpande, P Patel, M Bailey in Blood Cancer Journal (2017)